IL20 and leukemia: In response to stimulation with IL20 in vitro, we also observed a pronounced cycling activity of CLOCK-transduced leukemia T-cells (Fig. 5B), as well as decrease of the fraction of cells at the early apoptotic stage (Fig. S9), confirming that CLOCK-overexpressing cells are more responsive to IL20 treatment.